Stonebridge Capital Advisors’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-333
Closed -$25.5K 395
2023
Q3
$25.5K Sell
333
-107
-24% -$8.88K ﹤0.01% 456
2023
Q2
$36.8K Buy
440
+252
+134% +$20.5K ﹤0.01% 411
2023
Q1
$15.9K Buy
188
+55
+41% +$4.72K ﹤0.01% 542
2022
Q4
$10.8K Buy
133
+106
+393% +$8.54K ﹤0.01% 584
2022
Q3
$2K Buy
27
+8
+42% +$719 ﹤0.01% 800
2022
Q2
$2K Sell
19
-20
-51% -$2.07K ﹤0.01% 803
2022
Q1
$4K Hold
39
﹤0.01% 799
2021
Q4
$5K Hold
39
﹤0.01% 733
2021
Q3
$4K Buy
39
+20
+105% +$2.21K ﹤0.01% 736
2021
Q2
$2K Hold
19
﹤0.01% 788
2021
Q1
$2K Buy
+19
New +$2.06K ﹤0.01% 831
2020
Q1
Sell
-7
Closed -$1K 794
2019
Q4
$1K Hold
7
﹤0.01% 781
2019
Q3
$1K Hold
7
﹤0.01% 776
2019
Q2
$1K Buy
+7
New +$532 ﹤0.01% 823

Other funds holding EMN

Stonebridge Capital Advisors's EMN Position: Q4 2023 in Review

Stonebridge Capital Advisors sold out of Eastman Chemical (EMN) in Q4 2023, closing a stake of 333 shares — an estimated $25.5K sold.

Stonebridge Capital Advisors first reported a position in EMN in Q2 2019 and held it in 14 quarters. The position peaked at $36.8K in Q2 2023. 712 funds tracked by Wall St. Rank hold EMN as of Q4 2023.

  • Stonebridge Capital Advisors reported no remaining Eastman Chemical position as of Q4 2023 after selling out during the quarter.
  • Stonebridge Capital Advisors sold 333 Eastman Chemical shares in Q4 2023, an estimated $25.5K.
  • Stonebridge Capital Advisors first reported a position in Eastman Chemical in Q2 2019 and held it in 14 quarters.
  • Stonebridge Capital Advisors's Eastman Chemical position peaked at $36.8K in Q2 2023.
  • 712 funds tracked by Wall St. Rank held Eastman Chemical as of Q4 2023.

Based on Stonebridge Capital Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.